Huge leap for Tata Power: Q2FY25 profit surges 51%, driven by solar and e-mobility push!

Huge leap for Tata Power: Q2FY25 profit surges 51%, driven by solar and e-mobility push!

In a remarkable demonstration of growth and resilience, Tata Power, a major player in India’s energy sector, has reported its highest-ever quarterly profit of ₹1,533 crore for Q2FY25, marking a 51% year-on-year increase. The company also achieved an EBITDA of ₹3,808 crore, a 23% YoY growth, propelled by expanded solar manufacturing and favourable regulatory conditions. […]

Unicommerce eSolutions reports strong Q2FY25 with 21% PAT growth

Unicommerce eSolutions reports strong Q2FY25 with 21% PAT growth

Unicommerce eSolutions Limited has posted a remarkable 21% increase in Profit After Tax (PAT) year-on-year for Q2FY25, reaching INR 44.7 million, while reporting a 13% revenue growth to INR 293.1 million. This performance, announced on October 28, 2024, also marks an impressive 33.5% jump in adjusted EBITDA, reflecting the company’s strategic focus on client expansion, […]

Timex Group India Ltd’s best quarter yet: What’s driving the 37% revenue explosion?

Timex Group India Ltd’s best quarter yet: What’s driving the 37% revenue explosion?

Timex Group India Limited has announced its most successful quarter to date, reporting a remarkable 37% increase in revenue for the second quarter of FY 2024-25. The company, part of the globally recognized American watchmaking giant Timex Group, achieved a record quarterly revenue of ₹172 crores, driven by its strategic expansion across premium and luxury […]

Mankind Pharma expands dominance in women’s health with Bharat Serums and Vaccines acquisition

Mankind Pharma expands dominance in women’s health with Bharat Serums and Vaccines acquisition

Mankind Pharma Limited has announced the completion of its acquisition of Bharat Serums and Vaccines Limited (BSV) for a massive INR 13,768 Crore. This strategic acquisition, finalized on October 23, 2024, is set to bolster Mankind’s presence in the women’s health and fertility market, positioning it as a leader in the sector. The acquisition, undertaken […]

Mahindra Logistics reports 11.5% revenue growth in Q2 FY25, reducing losses amid strategic expansion

Mahindra Logistics reports 11.5% revenue growth in Q2 FY25, reducing losses amid strategic expansion

Mahindra Logistics Limited (MLL), a key player in India’s integrated logistics and mobility solutions sector, has reported an 11.5% year-on-year revenue increase for the second quarter of FY25, reaching ₹1,521 crores, as disclosed in its latest financial results. Despite ongoing challenges, the company achieved a reduction in losses, signalling the effectiveness of its strategic investments […]

Multi Commodity Exchange of India reports 73% increase in quarterly operational revenue for Q2 FY24-25

Multi Commodity Exchange of India reports 73% increase in quarterly operational revenue for Q2 FY24-25

India’s largest commodity derivatives exchange, Multi Commodity Exchange of India Ltd (MCX), reported an impressive 73% year-on-year increase in its operational revenue for the second quarter of FY24-25, reaching ₹285.58 crore. This sharp rise in revenue highlights MCX’s growing market dominance, bolstered by a consistent rise in trading volumes, especially in the options segment. For […]

HDFC Bank’s bold strategy delivers 6% profit boost in Q2 FY25! What’s next for investors?

HDFC Bank’s bold strategy delivers 6% profit boost in Q2 FY25! What’s next for investors?

HDFC Bank Limited announced its unaudited financial results for Q2 FY25, showcasing a 6% year-on-year increase in net profit to ₹16,820.97 crore. This result reflects the bank’s steady growth trajectory, despite a marginal rise in its gross non-performing assets (GNPAs), which now stand at 1.36%. The net NPA ratio, however, remains stable at 0.41%. Key […]

UCO Bank reports 50% surge in Q2 FY 2024-25 profits, boosted by retail and MSME growth

UCO Bank reports 50% surge in Q2 FY 2024-25 profits, boosted by retail and MSME growth

UCO Bank has announced its financial results for the second quarter of FY 2024-25, revealing a substantial increase in its profitability. The state-owned lender posted a net profit of ₹603 crore for the quarter ending 30 September 2024, marking a 50% year-on-year growth from ₹402 crore reported in the same period last year. The operating […]

Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence

Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence

Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce Fludrocortisone Acetate Tablets USP, 0.1 mg, according to a press release on 17 October 2024. The company is set to manufacture the drug at its state-of-the-art facility in Moraiya, Ahmedabad, India. This development further strengthens Zydus’ foothold […]